mannosamine has been researched along with lactic acid in 2 studies
| Studies (mannosamine) | Trials (mannosamine) | Recent Studies (post-2010) (mannosamine) | Studies (lactic acid) | Trials (lactic acid) | Recent Studies (post-2010) (lactic acid) |
|---|---|---|---|---|---|
| 144 | 0 | 44 | 46,263 | 3,349 | 19,053 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bryson, H; Bunning, RA; Buttle, DJ; Johnatty, RN; Kozaci, LD | 1 |
| Alam, MA; Panda, AK; Singh, AT; Talegaonkar, S; Tariq, M | 1 |
2 other study(ies) available for mannosamine and lactic acid
| Article | Year |
|---|---|
Evidence that the inhibition of cartilage proteoglycan breakdown by mannosamine is not mediated via inhibition of glycosylphosphatidylinositol anchor formation.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Animals; Cartilage; Cattle; Chondrocytes; Culture Techniques; Female; Glycosylphosphatidylinositols; Hexosamines; Humans; Interleukin-1; Lactic Acid; Nasal Septum; Proteoglycans; Tissue Plasminogen Activator; Tumor Necrosis Factor-alpha; Urokinase-Type Plasminogen Activator | 2000 |
Surface decorated nanoparticles as surrogate carriers for improved transport and absorption of epirubicin across the gastrointestinal tract: Pharmacokinetic and pharmacodynamic investigations.
Topics: Animals; Antibiotics, Antineoplastic; Biological Transport; Caco-2 Cells; Cell Survival; Drug Carriers; Drug Liberation; Epirubicin; Gastrointestinal Tract; Hexosamines; Humans; Ileum; Intestinal Absorption; Lactic Acid; MCF-7 Cells; Nanoparticles; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Wistar; Surface Properties | 2016 |